AHA GUIDELINES Bundle (free trial)

2017 Update Incorporated - Valvular Heart Disease

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/362033

Contents of this Issue

Navigation

Page 28 of 63

29 Table 17. Primary MR Intervention (cont'd) Recommendations COR LOE Concomitant mitral valve repair is reasonable in patients with chronic moderate primary MR (stage B) when undergoing cardiac surgery for other indications. IIa C Mitral valve surgery may be considered in symptomatic patients with chronic severe primary MR and LVEF <30% (stage D). IIb C Transcatheter mitral valve repair may be considered for severely symptomatic patients (NYHA class III to IV) with chronic severe primary MR (stage D) who have favorable anatomy for the repair procedure and a reasonable life expectancy but who have a prohibitive surgical risk because of severe comorbidities and remain severely symptomatic despite optimal guideline-directed management and therapy (GDMT) for HF. IIb B MVR should NOT be performed for the treatment of isolated severe primary MR limited to less than one half of the posterior leaflet unless mitral valve repair has been attempted and was unsuccessful. III: Harm B

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - 2017 Update Incorporated - Valvular Heart Disease